Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy

F. Tagliaferri, I. Sirovich, F. Stipa, M. Giovanna Valente, G. Pupelis, S. Tremiterra

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccine therapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.

Original languageEnglish
Pages (from-to)591-596
Number of pages6
JournalRecenti Progressi in Medicina
Volume85
Issue number12
Publication statusPublished - 1994

Fingerprint

Active Immunotherapy
Cancer Vaccines
Clinical Trials
Neoplasms
Neoplasm Antigens
Disease-Free Survival
Immunity
Therapeutics

Keywords

  • solid tumors
  • specific immunotherapy
  • vaccine therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tagliaferri, F., Sirovich, I., Stipa, F., Giovanna Valente, M., Pupelis, G., & Tremiterra, S. (1994). Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy. Recenti Progressi in Medicina, 85(12), 591-596.

Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy. / Tagliaferri, F.; Sirovich, I.; Stipa, F.; Giovanna Valente, M.; Pupelis, G.; Tremiterra, S.

In: Recenti Progressi in Medicina, Vol. 85, No. 12, 1994, p. 591-596.

Research output: Contribution to journalArticle

Tagliaferri, F, Sirovich, I, Stipa, F, Giovanna Valente, M, Pupelis, G & Tremiterra, S 1994, 'Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy', Recenti Progressi in Medicina, vol. 85, no. 12, pp. 591-596.
Tagliaferri, F. ; Sirovich, I. ; Stipa, F. ; Giovanna Valente, M. ; Pupelis, G. ; Tremiterra, S. / Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy. In: Recenti Progressi in Medicina. 1994 ; Vol. 85, No. 12. pp. 591-596.
@article{881fc26f5b074136bd9438a8e2060489,
title = "Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy",
abstract = "Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccine therapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.",
keywords = "solid tumors, specific immunotherapy, vaccine therapy",
author = "F. Tagliaferri and I. Sirovich and F. Stipa and {Giovanna Valente}, M. and G. Pupelis and S. Tremiterra",
year = "1994",
language = "English",
volume = "85",
pages = "591--596",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "12",

}

TY - JOUR

T1 - Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy

AU - Tagliaferri, F.

AU - Sirovich, I.

AU - Stipa, F.

AU - Giovanna Valente, M.

AU - Pupelis, G.

AU - Tremiterra, S.

PY - 1994

Y1 - 1994

N2 - Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccine therapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.

AB - Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccine therapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.

KW - solid tumors

KW - specific immunotherapy

KW - vaccine therapy

UR - http://www.scopus.com/inward/record.url?scp=0028574347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028574347&partnerID=8YFLogxK

M3 - Article

C2 - 7899685

AN - SCOPUS:0028574347

VL - 85

SP - 591

EP - 596

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 12

ER -